MYC and cancer: Lung tumors driven by strong cancer drivers (mutant EGFR and Kras) harbored few mutations in cancer-related genes, whereas tumors driven by MYC, a weak driver in the murine lung, harbored recurrent clonal oncogenic KRAS mutations [83].